STERIS Work in process increased by 3.7% to $92.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $94.26M to $92.90M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 11.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.12M | $79.43M | $77.34M | $76.02M | $107.27M | $103.07M | $103.90M | $97.76M | $117.59M | $109.83M | $117.88M | $98.30M | $111.30M | $107.37M | $94.26M | $83.10M | $89.50M | $89.60M | $92.90M |
| QoQ Change | — | +10.1% | -2.6% | -1.7% | +41.1% | -3.9% | +0.8% | -5.9% | +20.3% | -6.6% | +7.3% | -16.6% | +13.2% | -3.5% | -12.2% | -11.8% | +7.7% | +0.1% | +3.7% |
| YoY Change | — | — | — | — | +48.7% | +29.8% | +34.3% | +28.6% | +9.6% | +6.6% | +13.5% | +0.6% | -5.4% | -2.2% | -20.0% | -15.5% | -19.6% | -16.6% | -1.4% |
| % of Inventories | 12.2% | 14.1% | 13.0% | 13.2% | 17.3% | 16.0% | 15.0% | 16.2% | 15.3% | 13.4% | 13.8% | 14.6% | 15.9% | 15.6% | 14.5% | 14.3% | 14.0% | 13.6% | 13.8% |
| Share Change | — | +1.9pp | -1.1pp | +0.2pp | +4.1pp | -1.3pp | -1.0pp | +1.2pp | -0.9pp | -1.9pp | +0.4pp | +0.8pp | +1.4pp | -0.3pp | -1.1pp | -0.2pp | -0.3pp | -0.4pp | +0.2pp |